WEEKLY e-ALERT  [ BASIC EDITION ]
Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
Industry News
CFDA Approves Expanded Indication of Eisai's Aricept to Severe AD(12/14/2017 )  (Premium)
Ipsen, Zhejiang MedTech Enter Strategic Alliance for Tanakan in China(12/14/2017 )  (Premium)
Shanghai Establishes Regional Ethics Committee for Clinical Research(12/13/2017 )  (Premium)
Bayer Announces CFDA Approval of Stivarga as Second Line Treatment for HCC(12/13/2017 )  (Premium)
Galderma to Spin Off Drug Business in China(12/13/2017 )  (Premium)
Boai NKY Pharma to Buy BioVision for $290M(12/11/2017 )  (Premium)
BGI Genomics to Set Up JV with TCM Player Kangmei Pharma(12/11/2017 )  (free)
Ardelyx Announces License Agreement with Fosun for IBS Drug Candidate Tenapanor in China(12/11/2017 )  (Premium)
Bayer's Pharma Chief Praises China for Progress in New Drug Clinical Research and Development(12/11/2017 )  (Premium)
Regulatory News
CFDA Solicits Comments on Two Clinical Guidelines for Special Medical Purpose Formula Foods for IBD and Diabetes(12/13/2017 )  (Premium)
CFDI to Initiate Clinical Data Inspection of Five Drug Products (#16)(12/12/2017 )  (Premium)
General Health
Fujian Introduces New Policy to Differentiate Drug Products into Three Categories(12/15/2017 )  (Premium)
Product/R&D News
CFDA Accepts Innovent Biologics' NDA for PD-1 Candidate IBI308(12/14/2017 )  (Premium)
CFDA Approves Genscript's Clinical Trial Application for CAR-T Blood Cancer Therapy(12/11/2017 )  (Premium)
People in the News
Recent Executive Moves(12/15/2017 )  (Premium)
Other News
Upcoming Event: 8th Annual Generic International Asia Summit 2018(12/12/2017 )  (free)
Upcoming Event: Wellness China 2018(12/11/2017 )  (free)
Upcoming Event: Asia Clinical Trials Innovation Summit 2018(12/11/2017 )  (free)
© Wicon International GroupˇˇSupport by: www.heightow.com Home | Site map | Contact Us | Links